Related references
Note: Only part of the references are listed.Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications
Ryota Tamura et al.
MEDICAL ONCOLOGY (2020)
Rapid stromal remodeling by short-term VEGFR2 inhibition increases chemotherapy delivery in esophagogastric adenocarcinoma
Anne Steins et al.
MOLECULAR ONCOLOGY (2020)
Tumor microenvironment components: Allies of cancer progression
Pablo Igor Ribeiro Franco et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
YAP/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy
Barry J. Thompson
BIOESSAYS (2020)
An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates
Jermaine Goveia et al.
CANCER CELL (2020)
Induction of AP-1 by YAP/TAZ contributes to cell proliferation and organ growth
Ja Hyun Koo et al.
GENES & DEVELOPMENT (2020)
DLC1 is a direct target of activated YAP/TAZ that drives collective migration and sprouting angiogenesis
Miesje van der Stoel et al.
JOURNAL OF CELL SCIENCE (2020)
Combining microenvironment normalization strategies to improve cancer immunotherapy
Fotios Mpekris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer
Chenxi Zhao et al.
ACTA PHARMACEUTICA SINICA B (2020)
Tumor microenvironment complexity and therapeutic implications at a glance
Roghayyeh Baghba et al.
CELL COMMUNICATION AND SIGNALING (2020)
Single-Cell RNA Sequencing Maps Endothelial Metabolic Plasticity in Pathological Angiogenesis
Katerina Rohlenova et al.
CELL METABOLISM (2020)
YAP1 and TAZ negatively control bone angiogenesis by limiting hypoxia-inducible factor signaling in endothelial cells
Kishor K. Sivaraj et al.
ELIFE (2020)
The Crosstalk Between Hippo-YAP Pathway and Innate Immunity
Shuai Wang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Matrix mechanotransduction mediated by thrombospondin-1/integrin/YAP in the vascular remodeling
Yoshito Yamashiro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma
Nayoung Kim et al.
NATURE COMMUNICATIONS (2020)
Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment
Wenjie Yang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Basic and Therapeutic Aspects of Angiogenesis Updated
Guy Eelen et al.
CIRCULATION RESEARCH (2020)
Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer
Ying Shen et al.
CANCER CELL (2020)
The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression
Chao Tu et al.
CELL PROLIFERATION (2020)
Mechanical stress triggers nuclear remodeling and the formation of transmembrane actin nuclear lines with associated nuclear pore complexes
Laura M. Hoffman et al.
MOLECULAR BIOLOGY OF THE CELL (2020)
YAP promotes endothelial barrier repair by repressing STAT3/VEGF
Xiaofang Fan et al.
LIFE SCIENCES (2020)
Tumoural activation of TLR3-SLIT2 axis in endothelium drives metastasis
Bernardo Tavora et al.
NATURE (2020)
A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy
Ajaybabu Pobbati et al.
THERANOSTICS (2020)
Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges
John D. Martin et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 81 (2019)
A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK
Xiaodong Feng et al.
CANCER CELL (2019)
YAP and TAZ limit cytoskeletal and focal adhesion maturation to enable persistent cell motility
Devon E. Mason et al.
JOURNAL OF CELL BIOLOGY (2019)
Hypoxic cancer-associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling
Fernanda G. Kugeratski et al.
SCIENCE SIGNALING (2019)
Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway
Karthik Reddy Kami Reddy et al.
ACS COMBINATORIAL SCIENCE (2019)
The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry
Taha Azad et al.
CELLS (2019)
Tumor Angiogenesis Is Differentially Regulated by Phosphorylation of Endothelial Cell Focal Adhesion Kinase Tyrosines-397 and-861
Ana-Rita Pedrosa et al.
CANCER RESEARCH (2019)
The Emerging Role of YAP/TAZ in Tumor Immunity
Zhaoji Pan et al.
MOLECULAR CANCER RESEARCH (2019)
Integrins as biomechanical sensors of the microenvironment
Jenny Z. Kechagia et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Limitations of Anti-Angiogenic Treatment of Tumors
Domenico Ribatti et al.
TRANSLATIONAL ONCOLOGY (2019)
Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
Gandhi T. K. Boopathy et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
DLC1 deficiency and YAP signaling drive endothelial cell contact inhibition of growth and tumorigenesis
Lisa Ritchey et al.
ONCOGENE (2019)
CCN1 interlinks integrin and hippo pathway to autoregulate tip cell activity
Myo-Hyeon Park et al.
ELIFE (2019)
Trends and Challenges in Tumor Anti-Angiogenic Therapies
Jozsef Jaszai et al.
CELLS (2019)
Control of cellular responses to mechanical cues through YAP/TAZ regulation
Ishani Dasgupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Biomechanical signaling within the developing zebrafish heart attunes endocardial growth to myocardial chamber dimensions
Dorothee Bornhorst et al.
NATURE COMMUNICATIONS (2019)
YAPping about and not forgetting TAZ
Bernard A. Callus et al.
FEBS LETTERS (2019)
SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis
John M. Lamar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction
Yongfa Zheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
TAZ Expression on Endothelial Cells Is Closely Related to Blood Vascular Density and VEGFR2 Expression in Astrocytomas
Chenyue Xu et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2019)
Role of Matrix Metalloproteinases in Angiogenesis and Cancer
Saray Quintero-Fabian et al.
FRONTIERS IN ONCOLOGY (2019)
DDAH1 regulates apoptosis and angiogenesis in human fetal pulmonary microvascular endothelial cells
Jennifer K. Trittmann et al.
PHYSIOLOGICAL REPORTS (2019)
YAP Promotes VEGFA Expression and Tumor Angiogenesis Though Gli2 in Human Renal Cell Carcinoma
Shan Xu et al.
ARCHIVES OF MEDICAL RESEARCH (2019)
YAP/TAZ Signaling and Resistance to Cancer Therapy
Chan D. K. Nguyen et al.
TRENDS IN CANCER (2019)
YAP and TAZ: a signalling hub of the tumour microenvironment
Francesca Zanconato et al.
NATURE REVIEWS CANCER (2019)
Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression
David Sanchez-Martin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Hold Me, but Not Too Tight-Endothelial Cell-Cell Junctions in Angiogenesis
Anna Szymborska et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression
David Sanchez-Martin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
EphB4 mediates resistance to antiangiogenic therapy in experimental glioma
Christian Uhl et al.
ANGIOGENESIS (2018)
LncRNA UCA1 promotes migration and invasion in pancreatic cancer cells via the Hippo pathway
Meiting Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis
Xin Cui et al.
BIOMATERIALS (2018)
Knockdown of lncRNA GHET1 suppresses cell proliferation, invasion and LATS1/YAP pathway in non small cell lung cancer
Zhen-Biao Guan et al.
CANCER BIOMARKERS (2018)
Endothelial-mesenchymal transition in atherosclerosis
Celine Souilhol et al.
CARDIOVASCULAR RESEARCH (2018)
YAP regulates liver size and function
Norio Miyamura et al.
CELL CYCLE (2018)
Yes-Associated Protein Promotes Angiogenesis via Signal Transducer and Activator of Transcription 3 in Endothelial Cells
Jinlong He et al.
CIRCULATION RESEARCH (2018)
Contribution of Tumor Endothelial Cells in Cancer Progression
Kyoko Hida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Tension-dependent regulation of mammalian Hippo signaling through LIMD1
Consuelo Ibar et al.
JOURNAL OF CELL SCIENCE (2018)
Overexpression of SHCBP1 promotes migration and invasion in gliomas by activating the NF-κB signaling pathway
Yanqing Zhou et al.
MOLECULAR CARCINOGENESIS (2018)
YAP/TAZ upstream signals and downstream responses
Antonio Totaro et al.
NATURE CELL BIOLOGY (2018)
Phenotype molding of stromal cells in the lung tumor microenvironment
Diether Lambrechts et al.
NATURE MEDICINE (2018)
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dal Fukurnura et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2
Joao Incio et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Crosstalk between YAP/TAZ and Notch Signaling
Antonio Totaro et al.
TRENDS IN CELL BIOLOGY (2018)
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
Marco B. Schaaf et al.
CELL DEATH & DISEASE (2018)
Downregulation of BIRC5 inhibits the migration and invasion of esophageal cancer cells by interacting with the PI3K/Akt signaling pathway
Xiaobin Shang et al.
ONCOLOGY LETTERS (2018)
A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis
T. Azad et al.
NATURE COMMUNICATIONS (2018)
Mechanotransduction in talin through the interaction of the R8 domain with DLC1
Alexander William M. Haining et al.
PLOS BIOLOGY (2018)
YAP and TAZ regulate adherens junction dynamics and endothelial cell distribution during vascular development
Filipa Neto et al.
ELIFE (2018)
YAP/TAZ Activation as a Target for Treating Metastatic Cancer
Janine S. A. Warren et al.
CANCERS (2018)
Unraveling the Role of Angiogenesis in Cancer Ecosystems
Iratxe Zuazo-Gaztelu et al.
FRONTIERS IN ONCOLOGY (2018)
Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis
Alexander Greenhough et al.
EMBO MOLECULAR MEDICINE (2018)
Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress
Xiaodong Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
A feed forward loop enforces YAP/TAZ signaling during tumorigenesis
Mandeep K. Gill et al.
NATURE COMMUNICATIONS (2018)
TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells
Dana Elster et al.
NATURE COMMUNICATIONS (2018)
Zebrafish mutants and TEAD reporters reveal essential functions for Yap and Taz in posterior cardinal vein development
Matteo Astone et al.
SCIENTIFIC REPORTS (2018)
Stiffness-Induced Endothelial DLC-1 Expression Forces Leukocyte Spreading through Stabilization of the ICAM-1 Adhesome
Lilian Schimmel et al.
CELL REPORTS (2018)
YAP via interacting with STAT3 regulates VEGF-induced angiogenesis in human retinal microvascular endothelial cells
Manhui Zhu et al.
EXPERIMENTAL CELL RESEARCH (2018)
Convergence of VEGF and YAP/TAZ signaling: Implications for angiogenesis and cancer biology
Ameer L. Elaimy et al.
SCIENCE SIGNALING (2018)
Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA)
Karthik Kami Reddy et al.
ANGIOGENESIS (2018)
CD31 Expression Determines Redox Status and Chemoresistance in Human Angiosarcomas
Vivek Venkataramani et al.
CLINICAL CANCER RESEARCH (2018)
Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
Oleg Dobrokhotov et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
TRIP6 inhibits Hippo signaling in response to tension at adherens junctions
Shubham Dutta et al.
EMBO REPORTS (2018)
Matrix stiffening promotes a tumor vasculature phenotype
Francois Bordeleau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Angiomotin Family Members: Oncogenes or Tumor Suppressors?
Meng Lv et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression
Zhaoji Pan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
YAP/TAZ regulates sprouting angiogenesis and vascular barrier maturation
Jongshin Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis
Changliang Peng et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Mechanobiology of YAP and TAZ in physiology and disease
Tito Panciera et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
YAP/TAZ-CDC42 signaling regulates vascular tip cell migration
Masahide Sakabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Human Adipose-Derived Mesenchymal Stem Cell-Secreted CXCL1 and CXCL8 Facilitate Breast Tumor Growth by Promoting Angiogenesis
Yuan Wang et al.
STEM CELLS (2017)
The TAZ-miR-224-SMAD4 axis promotes tumorigenesis in osteosarcoma
Jianjun Ma et al.
CELL DEATH & DISEASE (2017)
YAP regulates cell mechanics by controlling focal adhesion assembly
Giorgia Nardone et al.
NATURE COMMUNICATIONS (2017)
The tumor suppressor RASSF1A induces the YAP1 target gene ANKRD1 that is epigenetically inactivated in human cancers and inhibits tumor growth
Adriana P. Jimenez et al.
ONCOTARGET (2017)
Role of tumor microenvironment in tumorigenesis
Maonan Wang et al.
JOURNAL OF CANCER (2017)
Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review
Ahmed M. Al-Abd et al.
JOURNAL OF ADVANCED RESEARCH (2017)
Yap/Taz transcriptional activity is essential for vascular regression via Ctgf expression and actin polymerization
Ayumi Nagasawa-Masuda et al.
PLOS ONE (2017)
Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis
Norihiko Sakai et al.
SCIENTIFIC REPORTS (2017)
Force Triggers YAP Nuclear Entry by Regulating Transport across Nuclear Pores
Alberto Elosegui-Artola et al.
CELL (2017)
A miR-135b-TAZ positive feedback loop promotes epithelial-mesenchymal transition (EMT) and tumorigenesis in osteosarcoma
Shuying Shen et al.
CANCER LETTERS (2017)
A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1
Nikki Buijs et al.
ANGIOGENESIS (2017)
YAP/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis
Xiaohong Wang et al.
DEVELOPMENTAL CELL (2017)
Down-regulation of DLC1 in endothelial cells compromises the angiogenesis process
Yi-Ping Shih et al.
CANCER LETTERS (2017)
CTGF promotes osteosarcoma angiogenesis by regulating miR-543/angiopoietin 2 signaling
Li-Hong Wang et al.
CANCER LETTERS (2017)
Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex
Honglong Wei et al.
CANCER SCIENCE (2017)
Role of Angiomotin-like 2 mono-ubiquitination on YAP inhibition
Miju Kim et al.
EMBO REPORTS (2016)
Adiponectin Induces CXCL1 Secretion From Cancer Cells and Promotes Tumor Angiogenesis by Inducing Stromal Fibroblast Senescence
Lun Cai et al.
MOLECULAR CARCINOGENESIS (2016)
Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment
Jin-Sung Park et al.
CANCER CELL (2016)
Exploring Novel Methods for Modulating Tumor Blood Vessels in Cancer Treatment
Ping-Pui Wong et al.
CURRENT BIOLOGY (2016)
Role of YAP/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction
Sirio Dupont
EXPERIMENTAL CELL RESEARCH (2016)
Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis
Clemens Lange et al.
EXPERIMENTAL EYE RESEARCH (2016)
SHCBP1 is over-expressed in breast cancer and is important in the proliferation and apoptosis of the human malignant breast cancer cell line
Wen Feng et al.
GENE (2016)
Mechanisms of Hippo pathway regulation
Zhipeng Meng et al.
GENES & DEVELOPMENT (2016)
Interstitial fluid pressure regulates collective invasion in engineered human breast tumors via Snail, vimentin, and E-cadherin
Alexandra S. Piotrowski-Daspit et al.
INTEGRATIVE BIOLOGY (2016)
TGF-β Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP/SMAD2 Nuclear Translocation
Dafni-Eleftheria Pefani et al.
MOLECULAR CELL (2016)
Integrin-YAP/TAZ-JNK cascade mediates atheroprotective effect of unidirectional shear flow
Li Wang et al.
NATURE (2016)
Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages
Teresa E. Peterson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis
Kuei-Chun Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Cellular Organization and Cytoskeletal Regulation of the Hipoo Signaling Network
Shuguo Sun et al.
TRENDS IN CELL BIOLOGY (2016)
New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics
Mingjing He et al.
CELL DIVISION (2016)
A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells
Le Qu et al.
NATURE COMMUNICATIONS (2016)
Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways
Biao Ma et al.
NATURE COMMUNICATIONS (2016)
Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells
Xiao-Yang Dai et al.
ONCOTARGET (2016)
Tead and AP1 Coordinate Transcription and Motility
Xiangfan Liu et al.
CELL REPORTS (2016)
Global Deletion of Ankrd1 Results in a Wound-Healing Phenotype Associated with Dermal Fibroblast Dysfunction
Susan E. Samaras et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis
Fei Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
ANKRD1 modulates inflammatory responses in C2C12 myoblasts through feedback inhibition of NF-κB signaling activity
Xin-Hua Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Tensin1 positively regulates RhoA activity through its interaction with DLC1
Yi-Ping Shih et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Dual-Action Combination Therapy Enhances Angiogenesis while Reducing Tumor Growth and Spread
Ping-Pui Wong et al.
CANCER CELL (2015)
CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer
Zhe-Wei Wei et al.
CANCER LETTERS (2015)
Interleukin-6 Stimulates Defective Angiogenesis
Ganga Gopinathan et al.
CANCER RESEARCH (2015)
Alternative Wnt Signaling Activates YAP/TAZ
Hyun Woo Park et al.
CELL (2015)
Functional interaction between CTGF and FPRL1 regulates VEGF-A-induced angiogenesis
Mi-Sook Lee et al.
CELLULAR SIGNALLING (2015)
The matricellular protein CCN1 controls retinal angiogenesis by targeting VEGF, Src homology 2 domain phosphatase-1 and Notch signaling
Hemabindu Chintala et al.
DEVELOPMENT (2015)
CRIM1, a newfound cancer-related player, regulates the adhesion and migration of lung cancer cells
Hui Zeng et al.
GROWTH FACTORS (2015)
YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors
Patricia Marti et al.
HEPATOLOGY (2015)
Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review)
Jun Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
Snail Is a Direct Target of Hypoxia-inducible Factor 1α (HIF1α) in Hypoxia-induced Endothelial to Mesenchymal Transition of Human Coronary Endothelial Cells
Xingbo Xu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The actin-binding protein EPS8 binds VE-cadherin and modulates YAP localization and signaling
Costanza Giampietro et al.
JOURNAL OF CELL BIOLOGY (2015)
Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway
Nam-Gyun Kim et al.
JOURNAL OF CELL BIOLOGY (2015)
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment
Matteo Santucci et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Francesca Zanconato et al.
NATURE CELL BIOLOGY (2015)
Mechanical strain induces E-cadherin-dependent Yap1 and β-catenin activation to drive cell cycle entry
Blair W. Benham-Pyle et al.
SCIENCE (2015)
Yes-associated protein regulates endothelial cell contact-mediated expression of angiopoietin-2
Hyun-Jung Choi et al.
NATURE COMMUNICATIONS (2015)
Epithelial derived CTGF promotes breast tumor progression via inducing EMT and collagen I fibers deposition
Xiaoping Zhu et al.
ONCOTARGET (2015)
HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma
Peng Liu et al.
ONCOTARGET (2015)
Transcriptional Co-repressor Function of the Hippo Pathway Transducers YAP and TAZ
Minchul Kim et al.
CELL REPORTS (2015)
YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers
Claudia Stein et al.
PLOS GENETICS (2015)
Stiff substrates increase YAP-signaling-mediated matrix metalloproteinase-7 expression
A. Nukuda et al.
ONCOGENESIS (2015)
BMP9 Crosstalk with the Hippo Pathway Regulates Endothelial Cell Matricellular and Chemokine Responses
Kira Young et al.
PLOS ONE (2015)
The Great Escape; the Hallmarks of Resistance to Antiangiogenic Therapy
Judy R. van Beijnum et al.
PHARMACOLOGICAL REVIEWS (2015)
The emerging roles of YAP and TAZ in cancer
Toshiro Moroishi et al.
NATURE REVIEWS CANCER (2015)
MIR-506 suppresses proliferation of hepatoma cells through targeting YAP mRNA 3′UTR
Yue Wang et al.
ACTA PHARMACOLOGICA SINICA (2014)
Molecular basis of the binding of YAP transcriptional regulator to the Erb134 receptor tyrosine kinase
Brett J. Schuchardt et al.
BIOCHIMIE (2014)
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Rakesh K. Jain
CANCER CELL (2014)
New strategy to control cell migration and metastasis regulated by CCN2/CTGF
Diego Pinheiro Aguiar et al.
CANCER CELL INTERNATIONAL (2014)
YAP/TAZ Incorporation in the β-Catenin Destruction Complex Orchestrates the Wnt Response
Luca Azzolin et al.
CELL (2014)
Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells
Wenjun Yu et al.
CELLULAR SIGNALLING (2014)
Crim1 maintains retinal vascular stability during development by regulating endothelial cell Vegfa autocrine signaling
Jieqing Fan et al.
DEVELOPMENT (2014)
Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells
Amanda Haage et al.
FASEB JOURNAL (2014)
Yap1 Is Required for Endothelial to Mesenchymal Transition of the Atrioventricular Cushion
Hui Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
ANKRD1 Acts as a Transcriptional Repressor of MMP13 via the AP-1 Site
Karinna Almodovar-Garcia et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma
Ken Shirabe et al.
LIVER INTERNATIONAL (2014)
Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
Bernardo Tavora et al.
NATURE (2014)
THE BIOLOGY OF YAP/TAZ: HIPPO SIGNALING AND BEYOND
Stefano Piccolo et al.
PHYSIOLOGICAL REVIEWS (2014)
Endothelial Depletion of Acvrl1 in Mice Leads to Arteriovenous Malformations Associated with Reduced Endoglin Expression
Simon Tual-Chalot et al.
PLOS ONE (2014)
Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration
Jonathan W. Haskins et al.
SCIENCE SIGNALING (2014)
Angiogenesis and Collagen Type IV Expression in Different Endothelial Cell Culture Systems
M. Bahramsoltani et al.
ANATOMIA HISTOLOGIA EMBRYOLOGIA (2014)
Apelin promotes lymphangiogenesis and lymph node metastasis
Judit Berta et al.
ONCOTARGET (2014)
A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing Factors
Mariaceleste Aragona et al.
CELL (2013)
MT1-MMP-Dependent Control of Skeletal Stem Cell Commitment via a β1-Integrin/YAP/TAZ Signaling Axis
Yi. Tang et al.
DEVELOPMENTAL CELL (2013)
COL4A3 expression correlates with pathogenesis, pathologic behaviors, and prognosis of gastric carcinomas
Xiao-cui Nie et al.
HUMAN PATHOLOGY (2013)
Matrix Metalloproteinase-1-mediated Up-regulation of Vascular Endothelial Growth Factor-2 in Endothelial Cells
Rafi Mazor et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Phosphorylation of Angiomotin by Lats1/2 Kinases Inhibits F-actin Binding, Cell Migration, and Angiogenesis
Xiaoming Dai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Endoglin regulates the activation and quiescence of endothelium by participating in canonical and non-canonical TGF-β signaling pathways
SunYoung Park et al.
JOURNAL OF CELL SCIENCE (2013)
Expression of CXCL1 in human endothelial cells induces angiogenesis through the CXCR2 receptor and the ERK1/2 and EGF pathways
Makito Miyake et al.
LABORATORY INVESTIGATION (2013)
Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts
Fernando Calvo et al.
NATURE CELL BIOLOGY (2013)
DDAH1 Deficiency Attenuates Endothelial Cell Cycle Progression and Angiogenesis
Ping Zhang et al.
PLOS ONE (2013)
Ablation of SGK1 Impairs Endothelial Cell Migration and Tube Formation Leading to Decreased Neo-Angiogenesis Following Myocardial Infarction
Elham Zarrinpashneh et al.
PLOS ONE (2013)
The p130 Isoform of Angiomotin Is Required for Yap-Mediated Hepatic Epithelial Cell Proliferation and Tumorigenesis
Chunling Yi et al.
SCIENCE SIGNALING (2013)
Impact of breast cancer surgery on angiogenesis circulating biomarkers: a prospective longitudinal study
Georgios K. Georgiou et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2013)
Eph Receptor Signaling and Ephrins
Erika M. Lisabeth et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
The Hippo pathway and human cancer
Kieran F. Harvey et al.
NATURE REVIEWS CANCER (2013)
Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling
Fa-Xing Yu et al.
CELL (2012)
β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
Joseph Rosenbluh et al.
CELL (2012)
Role of TAZ as Mediator of Wnt Signaling
Luca Azzolin et al.
CELL (2012)
Down-regulation of CXCL1 inhibits tumor growth in colorectal liver metastasis
Obul R. Bandapalli et al.
CYTOKINE (2012)
Migration dynamics of breast cancer cells in a tunable 3D interstitial flow chamber
Ulrike Haessler et al.
INTEGRATIVE BIOLOGY (2012)
Biology of the apelin-APJ axis in vascular formation
Hiroyasu Kidoya et al.
JOURNAL OF BIOCHEMISTRY (2012)
Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling
Moritz Felcht et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Survivin promotes glioma angiogenesis through vascular endothelial growth factor and basic fibroblast growth factor in vitro and in vivo
Peng Wang et al.
MOLECULAR CARCINOGENESIS (2012)
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
Yuhui Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Vascular Normalization as a Therapeutic Strategy for Malignant and Nonmalignant Disease
Shom Goel et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis
Kenneth E. Lipson et al.
FIBROGENESIS & TISSUE REPAIR (2012)
Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells
Roberta Mazzieri et al.
CANCER CELL (2011)
The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells
Michelangelo Cordenonsi et al.
CELL (2011)
CCN1/CYR61: the very model of a modern matricellular protein
Lester F. Lau
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Hippo pathway regulation by cell morphology and stress fibers
Ken-Ichi Wada et al.
DEVELOPMENT (2011)
Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein
Bin Zhao et al.
GENES & DEVELOPMENT (2011)
Angiomotin-like Proteins Associate with and Negatively Regulate YAP1
Wenqi Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin
Siew Wee Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Angiomotin-like2 Gene (amotl2) Is Required for Migration and Proliferation of Endothelial Cells during Angiogenesis
Yeqi Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet et al.
NATURE (2011)
Tumor angiogenesis: molecular pathways and therapeutic targets
Sara M. Weis et al.
NATURE MEDICINE (2011)
AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
M. Z. Xu et al.
ONCOGENE (2011)
NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES
Shom Goel et al.
PHYSIOLOGICAL REVIEWS (2011)
Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK)
Guorong Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Emerging Role of Apelin as a Therapeutic Target in Cancer: A Patent Review
Srujana Rayalam et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Pericytes and vessel maturation during tumor angiogenesis and metastasis
Ahmad Raza et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
A novel role for cardiac ankyrin repeat protein Ankrd1/CARP as a co-activator of the p53 tumor suppressor protein
Snezana Kojic et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Connective tissue growth factor is a substrate of ADAM28
Satsuki Mochizuki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Isolated tumor endothelial cells maintain specific character during long-term culture
Kohei Matsuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
DLC1 Negatively Regulates Angiogenesis in a Paracrine Fashion
Yi-Ping Shih et al.
CANCER RESEARCH (2010)
The Crumbs Complex Couples Cell Density Sensing to Hippo-Dependent Control of the TGF-β-SMAD Pathway
Xaralabos Varelas et al.
DEVELOPMENTAL CELL (2010)
Serum and Glucocorticoid-Inducible Kinase 1 (SGK1) Is Necessary for Vascular Remodeling During Angiogenesis
Catarina Catela et al.
DEVELOPMENTAL DYNAMICS (2010)
Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors
Rachel Ma Linger et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
Expression Profiling of ETS and MMP Factors in VEGF-Activated Endothelial Cells: Role of MMP-10 in VEGF-Induced Angiogenesis
Sun-Hee Heo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Apelin Expression in Human Non-small Cell Lung Cancer Role in Angiogenesis and Prognosis
Judit Berta et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Role of Angiopoietin-2 in Regulating Growth and Vascularity of Astrocytomas
Gelareh Zadeh et al.
JOURNAL OF ONCOLOGY (2010)
Targeting the tumour vasculature: insights from physiological angiogenesis
Alicia S. Chung et al.
NATURE REVIEWS CANCER (2010)
The role of the Angiopoietins in vascular morphogenesis
Markus Thomas et al.
ANGIOGENESIS (2009)
VEGFRs and Notch: a dynamic collaboration in vascular patterning
Lars Jakobsson et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2009)
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Marta Paez-Ribes et al.
CANCER CELL (2009)
Both TEAD-Binding and WW Domains Are Required for the Growth Stimulation and Oncogenic Transformation Activity of Yes-Associated Protein
Bin Zhao et al.
CANCER RESEARCH (2009)
VE-Cadherin-Mediated Cell-Cell Interaction Suppresses Sprouting via Signaling to MLC2 Phosphorylation
Sabu Abraham et al.
CURRENT BIOLOGY (2009)
TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition
Heng Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Thymidine Kinase 1 and Thymidine Phosphorylase Expression in Non-Small-cell Lung Carcinoma in Relation to Angiogenesis and Proliferation
J. Scott Brockenbrough et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2009)
Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation
Rosario Amato et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system
Hellmut G. Augustin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Ect2 links the PKCι-Par6α complex to Rac1 activation and cellular transformation
V. Justilien et al.
ONCOGENE (2009)
Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis
Y. Li et al.
ONCOGENE (2009)
Endoglin in angiogenesis and vascular diseases
Peter ten Dijke et al.
ANGIOGENESIS (2008)
MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation
Maria Praskova et al.
CURRENT BIOLOGY (2008)
Premenstrual regulation of the pro-angiogenic factor CYR61 in human endometrium
Isabella Gashaw et al.
ENDOCRINOLOGY (2008)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
Deleted in liver cancer-1 (DLC-1): A tumor suppressor not just for liver
Yi-Chun Liao et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
The role of adherens junctions and VE-cadherin in the control of vascular permeability
Elisabetta Dejana et al.
JOURNAL OF CELL SCIENCE (2008)
TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal
Xaralabos Varelas et al.
NATURE CELL BIOLOGY (2008)
STAT3: A critical transcription activator in angiogenesis
Zhong Chen et al.
MEDICINAL RESEARCH REVIEWS (2008)
Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: Correlation with the angiogenesis and clinical outcome
Zhe Shao et al.
ORAL ONCOLOGY (2008)
Modes of resistance to anti-angiogenic therapy
Gabriele Bergers et al.
NATURE REVIEWS CANCER (2008)
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Kathy Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Apelin is a potent activator of tumour neoangiogenesis
S. C. Sorli et al.
ONCOGENE (2007)
Tumour vascularization: sprouting angiogenesis and beyond
Femke Hillen et al.
CANCER AND METASTASIS REVIEWS (2007)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Angiopoietin: A TIE(d) balance in tumor angiogenesis
Winston S. N. Shim et al.
MOLECULAR CANCER RESEARCH (2007)
Genes that distinguish physiological and pathological angiogenesis
Steven Seaman et al.
CANCER CELL (2007)
Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis
Roland E. Kaelin et al.
DEVELOPMENTAL BIOLOGY (2007)
The BTB-Kelch protein KLEIP controls endothelial migration and sprouting angiogenesis
Tanju G. Nacak et al.
CIRCULATION RESEARCH (2007)
Crim1(KST264/KST264) mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development
Lorine Wilkinson et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
DLC-1: a Rho GTPase-activating protein and tumour suppressor
Marian E. Durkin et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer
Alan Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherin
Julie Gavard et al.
NATURE CELL BIOLOGY (2006)
Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells
Christopher Daly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Rapid vascular regrowth in tumors after reversal of VEGF inhibition
Michael R. Mancuso et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
The proangiogenic phenotype of human tumor-derived endothelial cells depends on thrombospondin-1 downregulation via phosphatidylinositol 3-kinase/Akt pathway
Benedetta Bussolati et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer
DZ Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth
N Kertesz et al.
BLOOD (2006)
Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression
M Héroult et al.
EXPERIMENTAL CELL RESEARCH (2006)
EphB4 controls blood vascular morphogenesis during postnatal angiogenesis
R Erber et al.
EMBO JOURNAL (2006)
Lowering of tumor interstitial fluid pressure reduces tumor cell proliferation in a xenograft tumor model
Matthias Hofmann et al.
NEOPLASIA (2006)
Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation
U Fiedler et al.
NATURE MEDICINE (2006)
A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome
M Murakami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Multiple roles for the receptor tyrosine kinase Axl in tumor formation
SJ Holland et al.
CANCER RESEARCH (2005)
Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis
F Yang et al.
CANCER RESEARCH (2005)
Pathophysiological consequences of VEGF-induced vascular permeability
SM Weis et al.
NATURE (2005)
Magic roundabout, a tumor endothelial marker: Expression and signaling
P Seth et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
M Presta et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
EH Chan et al.
ONCOGENE (2005)
Different effects of angiopoietin-2 in different vascular beds in the eye: new vessels are most sensitive
Y Oshima et al.
FASEB JOURNAL (2005)
Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor
M Gallicchio et al.
BLOOD (2005)
The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism
M Scharpfenecker et al.
JOURNAL OF CELL SCIENCE (2005)
DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development
ME Durkin et al.
FEBS LETTERS (2005)
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
DJ Hicklin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cellular abnormalities of blood vessels as targets in cancer
P Baluk et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2005)
CARP, a cardiac ankyrin repeat protein, is up-regulated during wound healing and induces angiogenesis in experimental granulation tissue
Y Shi et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A1
P Scapini et al.
JOURNAL OF IMMUNOLOGY (2004)
EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation
DM Brantley-Sieders et al.
JOURNAL OF CELL SCIENCE (2004)
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth
NK Noren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
CXC chemokines: the regulatory link between inflammation and angiogenesis
P Romagnani et al.
TRENDS IN IMMUNOLOGY (2004)
Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation
S Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist
P Dobrzanski et al.
CANCER RESEARCH (2004)
TGF-β induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways
T Nakagawa et al.
KIDNEY INTERNATIONAL (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Loss of HIF-1α in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis
N Tang et al.
CANCER CELL (2004)
Angiopoietin-2 enhances retinal vessel sensitivity to vascular endothelial growth factor
Y Oshima et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis
S Weis et al.
JOURNAL OF CELL BIOLOGY (2004)
Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction
F Lebrin et al.
EMBO JOURNAL (2004)
The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1
B Degryse et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Powerful and controllable angiogenesis by using gene-modified cells expressing human hepatocyte growth factor and thymidine kinase
Y Hisaka et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Role of Angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis
G Thurston
CELL AND TISSUE RESEARCH (2003)
Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity
B Wang et al.
CANCER CELL (2003)
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
H Gerhardt et al.
JOURNAL OF CELL BIOLOGY (2003)
Molecular regulation of vessel maturation
RK Jain
NATURE MEDICINE (2003)
Interleukin-17 promotes angiogenesis and tumor growth
M Numasaki et al.
BLOOD (2003)
CYR61 (CCN1) is essential for placental development and vascular integrity
FE Mo et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
CRIM1 is involved in endothelial cell capillary formation in vitro and is expressed in blood vessels in vivo
J Glienke et al.
MECHANISMS OF DEVELOPMENT (2002)
Role of angiogenesis in tumor growth and metastasis
J Folkman
SEMINARS IN ONCOLOGY (2002)
Cyr61 promotes breast tumorigenesis and cancer progression
MS Tsai et al.
ONCOGENE (2002)
Dimethylarginine dimethylaminohydrolase I enhances tumour growth and angiogenesis
V Kostourou et al.
BRITISH JOURNAL OF CANCER (2002)
Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo
IB Lobov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Stimulation of angiogenesis by Cyr61 gene: A new therapeutic candidate
V Fataccioli et al.
HUMAN GENE THERAPY (2002)
Activation of the Tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth
T Hawighorst et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
GL Niu et al.
ONCOGENE (2002)
Breast cancer -: Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease
D Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Urokinase/urokinase receptor and vitronectin/αvβ3 integrin induce chemotaxis and cytoskeleton reorganization through different signaling pathways
B Degryse et al.
ONCOGENE (2001)
The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization
K Ogawa et al.
ONCOGENE (2000)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Openings between defective endothelial cells explain tumor vessel leakiness
H Hashizume et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Control of apoptosis during angiogenesis by survivin expression in endothelial cells
DS O'Connor et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
